首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Synthesis and Acetylcholinesterase Inhibitory Evaluation of 4-(13-Dioxoisoindolin-2-yl)-N-Phenyl Benzamide Derivatives as Potential Anti-Alzheimer Agents
【2h】

Synthesis and Acetylcholinesterase Inhibitory Evaluation of 4-(13-Dioxoisoindolin-2-yl)-N-Phenyl Benzamide Derivatives as Potential Anti-Alzheimer Agents

机译:4-(13-二氧异吲哚-2-基)-N-苯基苯甲酰胺衍生物作为潜在的抗阿尔茨海默病药物的合成和乙酰胆碱酯酶抑制性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alzheimer᾽s disease is characterized by cognitive deficits, impaired long-term potentiation of learning and memory. A progressive reduction in cholinergic neurons in some areas of the brain such as cortex and hippocampus is related to the deficits in memory and cognitive function in Alzheimer’s disease (AD). In the current project a new series of phthalimide derivatives were synthesized. Phthalic anhydride was reacted with 4-aminobenzoic acid in the presence of triethylamine under reflux condition. Then, the obtained acidic derivative was utilized for preparation of final compounds via an amidation reaction through a carbodiimde coupling reaction. Anti-acetylcholinesterase activity of synthesized derivatives was assessed by Ellman᾽s test. Compound 4g in this series exhibited the highest inhibitory potency (IC50 = 1.1 ± 0.25 µM) compared to donepezil (IC50 = 0.41 ± 0.12 µM) as reference drug.
机译:阿尔茨海默氏病的特征是认知缺陷,学习和记忆的长期增强受损。大脑某些区域(例如皮质和海马体)胆碱能神经元的逐渐减少与阿尔茨海默氏病(AD)的记忆力和认知功能缺陷有关。在当前项目中,合成了一系列新的邻苯二甲酰亚胺衍生物。在三乙胺存在下,在回流条件下,将邻苯二甲酸酐与4-氨基苯甲酸反应。然后,将所获得的酸性衍生物用于经由碳二酰亚胺偶联反应的酰胺化反应而制备最终化合物。合成衍生物的抗乙酰胆碱酯酶活性通过Ellman检验进行评估。与作为参考药物的多奈哌齐(IC50 = 0.41±0.12 µM)相比,该系列化合物4g表现出最高的抑制效能(IC50 = 1.1±0.25 µM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号